<DOC>
	<DOCNO>NCT02138721</DOCNO>
	<brief_summary>The objective study evaluate role local treatment radical prostatectomy patient newly-diagnosed metastatic hormone-sensitive prostate cancer .</brief_summary>
	<brief_title>Local Treatment With RP Newly-diagnosed mPCa</brief_title>
	<detailed_description>Patients recently diagnose metastatic prostate cancer ( mPCa ) , meet eligibility criterion , give opportunity enroll study . Study Groups : After inclusion , patient request local treatment undergo radical prostatectomy ( RP ) pelvic lymph-node dissection ( PLND ) multi-disciplinary evaluation . This result local treatment group local treatment group . For ethical reason , randomization do . Follow-up : Patients undergo local treatment undergo current standard care institution . And besides intervention local treatment , patient receive current standard care . Routine follow-up visit , physical examination , laboratory test questionnaire , schedule every 3 month . A CT-scan ( abdomen-pelvis ) bone scan perform clinical progression diagnose suspected Castration Refractory PCa ( CRPC ) establish . Androgen Deprivation Therapy ( ADT ) initiate case one following : - symptom relate metastatic lesion ( ) - Prostate Specific Antigen ( PSA ) &gt; 50ng/ml doubling time ( PSA-DT ) &lt; 6 month ( start 3 month inclusion early ) The estimate number patient include local treatment arm 40 .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Diagnosis prostate adenocarcinoma , confirm histology Newly diagnosis metastatic disease ( stage TanyNanyM+ ) Life expectancy ≥2y base comorbid condition , WHO performance status 02 Written informed consent , male ≥18yo Willing expect comply study protocol followup schedule Multidisciplinary Oncologic Consultation ( MOC ) approval Previous local systemic treatment prostate cancer Metastatic brain disease , leptomeningeal disease imminent spinal cord compression Symptoms clearly related metastatic lesion Any previous current ( malignant ) disease , judgment responsible physician , likely interfere LoMP treatment assessment</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Metastatic Prostate Cancer</keyword>
	<keyword>Prostatectomy</keyword>
</DOC>